Clinical TRIAL Assistant The European Center for Cardiovascular Research (CERC) is a CRO specialized in the design and management of international clinical trials dedicated to cardiovascular diseases. Chaired by four interventional cardiologists, actors of clinical research for over 20 years, the CERC conducted clinical studies directly in line with the issues of cardiologists practicing in private or public hospitals. CERC is currently supporting thirty studies for industrial promotions but also manages more than 10 “investigators initiated trials” whose purpose is the treatment of conditions / comorbidities for which there is no satisfactory therapeutic strategy. CERC is an Entreprise à Mission. CERC is currently looking for a clinical trial assistant. Job description Perform general administrative tasks related to studies, upon request from Clinical Project Leaders Set up appropriate tracking tools Follow-up and tracking of all essential study documentation Maintenance of clinical studies files in order to ensure an appropriate filing of all study documents Follow-up of Investigator’s, subcontractor’s and committees members fees, upon request from Clinical Project Leaders Organization of meetings, teleconferences and booking of hotels for Clinical project Leaders Order specific supplies for studies Skills Fluent English Good computer skills The position is available immediately and is based in Massy, Essonne (91), France 12 reasons for joining us👉 https://www.cerc-europe.org/12-reasons/ INTERESTED ? RESUME COVER...
CERC is happy to announce the integration of a new function in the ARC HBR smartphone app. Its aim is to evaluate the individual trade-off between bleeding and thrombotic events in PCI patients at HBR. In 4 quick steps (see picture below), the user gets a clear result. A very helpful tool to tailor management of the HBR patients. To learn more about the method, read « Assessing the Risk of Bleeding vs Thrombotic Events at High Bleeding Risk After Coronary Stent Implantation » by Philip Urban, John Gregson, Ruth Owen et al. 👉 Available on App Store and Google...
Quality AssOCIATE The European Center for Cardiovascular Research (CERC) is a CRO specialized in the design and management of international clinical trials dedicated to cardiovascular diseases. Chaired by four interventional cardiologists, actors of clinical research for over 20 years, the CERC conducted clinical studies directly in line with the issues of cardiologists practicing in private or public hospitals. CERC is an Entreprise à Mission. CERC is currently looking for a Quality Associate to support its Quality team. Job description Contribution to the maintenance of the Quality and Process Management System Contribution to staff support regarding to Quality and Process Management System Planning and follow-up of audits Training related to the Quality Management system Qualifications Experience as Quality Associate Knowledge of applicable standards: appropriate clinical study regulations and guidelines, applicable quality standards Knowledge in written and spoken English Permanent employment contract. Position to be filled immediately. 12 reasons for joining us👉 https://www.cerc-europe.org/12-reasons/ INTERESTED ? RESUME COVER...
PHYSIO PCI Brief summary A Prospective, single-center , open label study to evaluate impact of coronary angioplasty on non-hyperhaemic pressure ratio in patients with coronary artery disease The principal objective of the study is to evaluate the impact of stenting in all-comers patients with coronary artery disease treated by PCI. The impact will be evaluated by physiological assessment (RFR measurement) before and after optimized PCI. Primary endpoints The primary endpoint will be the comparison between RFR before and after optimized PCI 3 (RFRpre vs. RFRfinal) in all included lesions. CERC Services Kick off activities, Clinical trial documentation, Regulatory submissions, Project management, eCRF management, Monitoring, SAE reporting activities, Statistical activities. Countries United Arab Emirates. Centers number 1 center managed by...
By Olivier Varenne, PI of the trial The CAOCT study is an investigator-initiated trial held thanks to a grant from Abbott Vascular and consists of a prospective, multi-centre, single cohort, diagnostic accuracy study. The study aims to compare the angio to the OCT to evaluate the ability to detect the culprit lesion. 131 patients, survivors of OHCA will be included in France, Serbia and Belgium. The trial is undergoing regulatory review. Out-of-hospital cardiac arrest (OHCA) is a leading cause of sudden death in Europe and the United States. Mortality is currently close to 40% among those patients who had been successfully resuscitated after OHCA associated with ventricular fibrillation or pulseless ventricular tachycardia. Coronary artery disease is observed in up to 70% of patients with OHCA and immediate coronary angiography. Current European and American guidelines recommend immediate coronary angiography with primary angioplasty in OHCA patients with ST-segment elevation on ECG after successful resuscitation. However, in patients with OHCA but without ST-segment elevation on ECG after return of spontaneous circulation (ROSC), systematic immediate coronary angiography has not been shown to improve 90-day survival when compared to delayed angiography. Moreover, detection of significant coronary artery disease in survivors of an OHCA does not necessarily translate into a causal link to explain cardiac arrest. Furthermore, the identification of the culprit lesion by coronary angiography among patients with an acute coronary syndrome (ACS) and no OHCA is challenging. In the Coronary Angiography after cardiac arrest (COACT) trial, a randomized controlled trial comparing immediate versus delayed coronary angiography after OHCA in patients without ST segment elevation on ECG, some degree of coronary artery disease was...
